You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Care

Global Liposomes Drug Delivery Market Analysis 2016-2020 and Forecast 2021-2026

Snapshot

Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
The global Liposomes Drug Delivery market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Liposomes Drug Delivery by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Liposomal doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Johnson & Johnson
Gilead Sciences
Luye Pharma
Sun Pharmaceutical
Pacira
Fudan-Zhangjiang
Sigma-Tau Group
Teva Pharmaceutical
CSPC
Novartis
Crucell
Celsion Corporation
Kingond Pharm
Shanghai New Asia
Spectrum Pharmaceuticals

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Fungal Infection Therapy
Cancer Therapy ( Tumor therapy)
Others

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Table of Contents
1 Industry Overview
1.1 Liposomes Drug Delivery Industry
Figure Liposomes Drug Delivery Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Liposomes Drug Delivery
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Liposomes Drug Delivery
1.2.2 Downstream
Table Application Segment of Liposomes Drug Delivery
Table Global Liposomes Drug Delivery Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Liposomes Drug Delivery Market by Type
3.1 By Type
3.1.1 Liposomal doxorubicin
Table Major Company List of Liposomal doxorubicin
3.1.2 Liposomal Amphoteracin B
Table Major Company List of Liposomal Amphoteracin B
3.1.3 Liposomal Paclitaxel
Table Major Company List of Liposomal Paclitaxel
3.1.4 Others
Table Major Company List of Others
3.2 Market Size
Table Global Liposomes Drug Delivery Market 2016-2020, by Type, in USD Million
Figure Global Liposomes Drug Delivery Market Growth 2016-2020, by Type, in USD Million
Table Global Liposomes Drug Delivery Market 2016-2020, by Type, in Volume
Figure Global Liposomes Drug Delivery Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Liposomes Drug Delivery Market Forecast 2021-2026, by Type, in USD Million
Table Global Liposomes Drug Delivery Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Johnson & Johnson (Company Profile, Sales Data etc.)
4.1.1 Johnson & Johnson Profile
Table Johnson & Johnson Overview List
4.1.2 Johnson & Johnson Products & Services
4.1.3 Johnson & Johnson Business Operation Conditions
Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Gilead Sciences (Company Profile, Sales Data etc.)
4.2.1 Gilead Sciences Profile
Table Gilead Sciences Overview List
4.2.2 Gilead Sciences Products & Services
4.2.3 Gilead Sciences Business Operation Conditions
Table Business Operation of Gilead Sciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Luye Pharma (Company Profile, Sales Data etc.)
4.3.1 Luye Pharma Profile
Table Luye Pharma Overview List
4.3.2 Luye Pharma Products & Services
4.3.3 Luye Pharma Business Operation Conditions
Table Business Operation of Luye Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Sun Pharmaceutical (Company Profile, Sales Data etc.)
4.4.1 Sun Pharmaceutical Profile
Table Sun Pharmaceutical Overview List
4.4.2 Sun Pharmaceutical Products & Services
4.4.3 Sun Pharmaceutical Business Operation Conditions
Table Business Operation of Sun Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Pacira (Company Profile, Sales Data etc.)
4.5.1 Pacira Profile
Table Pacira Overview List
4.5.2 Pacira Products & Services
4.5.3 Pacira Business Operation Conditions
Table Business Operation of Pacira (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Fudan-Zhangjiang (Company Profile, Sales Data etc.)
4.6.1 Fudan-Zhangjiang Profile
Table Fudan-Zhangjiang Overview List
4.6.2 Fudan-Zhangjiang Products & Services
4.6.3 Fudan-Zhangjiang Business Operation Conditions
Table Business Operation of Fudan-Zhangjiang (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Sigma-Tau Group (Company Profile, Sales Data etc.)
4.7.1 Sigma-Tau Group Profile
Table Sigma-Tau Group Overview List
4.7.2 Sigma-Tau Group Products & Services
4.7.3 Sigma-Tau Group Business Operation Conditions
Table Business Operation of Sigma-Tau Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Teva Pharmaceutical (Company Profile, Sales Data etc.)
4.8.1 Teva Pharmaceutical Profile
Table Teva Pharmaceutical Overview List
4.8.2 Teva Pharmaceutical Products & Services
4.8.3 Teva Pharmaceutical Business Operation Conditions
Table Business Operation of Teva Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 CSPC (Company Profile, Sales Data etc.)
4.9.1 CSPC Profile
Table CSPC Overview List
4.9.2 CSPC Products & Services
4.9.3 CSPC Business Operation Conditions
Table Business Operation of CSPC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Novartis (Company Profile, Sales Data etc.)
4.10.1 Novartis Profile
Table Novartis Overview List
4.10.2 Novartis Products & Services
4.10.3 Novartis Business Operation Conditions
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Crucell (Company Profile, Sales Data etc.)
4.11.1 Crucell Profile
Table Crucell Overview List
4.11.2 Crucell Products & Services
4.11.3 Crucell Business Operation Conditions
Table Business Operation of Crucell (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Celsion Corporation (Company Profile, Sales Data etc.)
4.12.1 Celsion Corporation Profile
Table Celsion Corporation Overview List
4.12.2 Celsion Corporation Products & Services
4.12.3 Celsion Corporation Business Operation Conditions
Table Business Operation of Celsion Corporation (Sales Revenue, Cost, Gross Margin)
4.13 Kingond Pharm (Company Profile, Sales Data etc.)
4.13.1 Kingond Pharm Profile
Table Kingond Pharm Overview List
4.13.2 Kingond Pharm Products & Services
4.13.3 Kingond Pharm Business Operation Conditions
Table Business Operation of Kingond Pharm (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.14 Shanghai New Asia (Company Profile, Sales Data etc.)
4.14.1 Shanghai New Asia Profile
Table Shanghai New Asia Overview List
4.14.2 Shanghai New Asia Products & Services
4.14.3 Shanghai New Asia Business Operation Conditions
Table Business Operation of Shanghai New Asia (Sales Revenue, Cost, Gross Margin)
4.15 Spectrum Pharmaceuticals (Company Profile, Sales Data etc.)
4.15.1 Spectrum Pharmaceuticals Profile
Table Spectrum Pharmaceuticals Overview List
4.15.2 Spectrum Pharmaceuticals Products & Services
4.15.3 Spectrum Pharmaceuticals Business Operation Conditions
Table Business Operation of Spectrum Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Liposomes Drug Delivery Sales Revenue 2016-2020, by Company, in USD Million
Table Global Liposomes Drug Delivery Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Liposomes Drug Delivery Sales Revenue Share in 2020, by Company, in USD Million
Table Global Liposomes Drug Delivery Sales Volume 2016-2020, by Company, in Volume
Table Global Liposomes Drug Delivery Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Liposomes Drug Delivery Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Liposomes Drug Delivery Market Concentration, in 2020
Figure Europe Liposomes Drug Delivery Market Market Concentration, in 2020
Figure Asia-Pacific Liposomes Drug Delivery MMarket Concentration, in 2020
Figure South America Liposomes Drug Delivery Market Concentration, in 2020
Figure Middle East & Africa Liposomes Drug Delivery Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Fungal Infection Therapy
Figure Liposomes Drug Delivery Demand in Fungal Infection Therapy, 2016-2020, in USD Million
Figure Liposomes Drug Delivery Demand in Fungal Infection Therapy, 2016-2020, in Volume
6.1.2 Demand in Cancer Therapy ( Tumor therapy)
Figure Liposomes Drug Delivery Demand in Cancer Therapy ( Tumor therapy), 2016-2020, in USD Million
Figure Liposomes Drug Delivery Demand in Cancer Therapy ( Tumor therapy), 2016-2020, in Volume
6.1.3 Demand in Others
Figure Liposomes Drug Delivery Demand in Others, 2016-2020, in USD Million
Figure Liposomes Drug Delivery Demand in Others, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Liposomes Drug Delivery Demand Forecast 2021-2026, by Application, in USD Million
Figure Liposomes Drug Delivery Market Growth 2021-2026, by Application, in USD Million
Figure Liposomes Drug Delivery Market Share in 2026, by Application, in USD Million
Table Liposomes Drug Delivery Demand Forecast 2021-2026, by Application, in Volume
Table Liposomes Drug Delivery Market Growth 2021-2026, by Application, in Volume
Table Liposomes Drug Delivery Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Liposomes Drug Delivery Production 2016-2020, by Region, in USD Million
Table Liposomes Drug Delivery Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Liposomes Drug Delivery Market 2016-2020, by Region, in USD Million
Table Global Liposomes Drug Delivery Market Share 2016-2020, by Region, in USD Million
Table Global Liposomes Drug Delivery Market 2016-2020, by Region, in Volume
Table Global Liposomes Drug Delivery Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Liposomes Drug Delivery Market Size and Growth 2016-2020, in USD Million
Figure North America Liposomes Drug Delivery Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Liposomes Drug Delivery Market Size 2016-2020, by Country, in USD Million
Table North America Liposomes Drug Delivery Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Liposomes Drug Delivery Market Size and Growth 2016-2020, in USD Million
Figure Europe Liposomes Drug Delivery Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Liposomes Drug Delivery Market Size 2016-2020, by Country, in USD Million
Table Europe Liposomes Drug Delivery Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Liposomes Drug Delivery Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Liposomes Drug Delivery Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Liposomes Drug Delivery Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Liposomes Drug Delivery Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Liposomes Drug Delivery Market Size and Growth 2016-2020, in USD Million
Figure South America Liposomes Drug Delivery Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Liposomes Drug Delivery Market Size 2016-2020, by Country, in USD Million
Table South America Liposomes Drug Delivery Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Liposomes Drug Delivery Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Liposomes Drug Delivery Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Liposomes Drug Delivery Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Liposomes Drug Delivery Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Liposomes Drug Delivery Market Forecast 2021-2026, by Region, in USD Million
Table Liposomes Drug Delivery Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
  • FORMAT: PDF
  • PUBLISHED DATE: Feb, 2021
  • NO OF PAGES: 44236